PPHM

lamborghini · #1 (**permalink**) 07-23-2007, 03:54 PM

PN 12:00 PPHM Peregrine Enters Contract Negotiations With U.S. DTRA for Hemorrhagic Fevers

TUSTIN, Calif., July 23 /PRNewswire-FirstCall/ -- Peregrine
Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical
company developing monoclonal antibodies for the treatment of cancer and
hepatitis C virus (HCV) infection, today announced that the company's proposal
to investigate its antiviral agent bavituximab and other
anti-phosphotidylserine (anti-PS) antibodies as potential therapies for
hemorrhagic fever virus (HFV) infections has been selected for a contract
award by the Defense Threat Reduction Agency (DTRA) of the U.S. Department of
Defense (DOD), pending negotiation of a final contract. In its notification
announcing the selection of Peregrine's proposal, DTRA stated that its goal is
to finalize the contract award within the next few months.

lamborghini · #2 (**permalink**) 07-23-2007, 03:55 PM

trading @ .79

lamborghini · #3 (**permalink**) 07-23-2007, 03:55 PM

big news imo

lamborghini · #4 (**permalink**) 07-23-2007, 03:56 PM

In the proposal submitted to the DTRA, Peregrine has sought funding of
approximately $44.5 million over the five years of the proposed project. The
DTRA accepted Peregrine's full proposal as the basis for contract
negotiations. The final scope of the contract award will be negotiated as
part of this process.

ron · #5 (**permalink**) 07-23-2007, 03:57 PM

going $0.805 now.